This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Los Angeles-based Banc of California announced the completion of its all-stock merger with PacWest Bancorp, which will take effect Dec. 1. Announced on Nov. 30, Pacific Western Bank, a subsidiary of PacWest Bancorp, has now merged into Banc of California meaning the combined bank will operate under the Banc of California name and brand. The Read More →
Santa Barbara-based Direct Relief is known for its giving nature, especially on a global scale, but in the last 15 years, it has made a more concerted effort to address the unmet needs of millions here at home — meaning both the U.S. and the Central Coast. On Nov. 21, the global nonprofit announced it Read More →
Two Central Coast law firms, Lowthorp Richards, McMillan, Miller & Templeman, and The Hathaway Law Firm, will merge effective on Jan. 1. The combined firm will operate as Lowthorp Richards, LLP, the practices announced on Nov. 30. Lowthorp Richards, McMillan, Miller & Templeman is based in Oxnard. The Hathaway Law Firm is in Ventura. The Read More →
Conejo Valley-based Acelyrin saw shares plummet more than 30% on Nov. 28 after the biotechnology startup announced an error in one of its trials for its main treatment. Acelyrin, which is a part of Westlake Village BioPartners investing portfolio, disclosed there was a programming error in a drug trial of izokibep, a treatment for psoriatic Read More →